Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph R Calabrese

Showing results (221-230 of 334) with videos related to

Pageof 34
Sort By:
Medgenmed : Medscape General Medicine|April 5, 2007
Predictors of bipolar disorder risk among patients currently treated for major depressionJoseph R Calabrese, David J Muzina, David E Kemp, et al.
The Journal of Clinical Psychiatry|May 17, 2007
Double-blind, placebo-controlled trial of divalproex monotherapy in the treatment of symptomatic youth at high risk for developing bipolar disorderRobert L Findling, Thomas W Frazier, Eric A Youngstrom, et al.
The American Journal on Addictions|August 19, 2010
Independent predictors for lifetime and recent substance use disorders in patients with rapid-cycling bipolar disorder: focus on anxiety disordersKeming Gao, Philip K Chan, Marcia L Verduin, et al.
Journal of Affective Disorders|February 1, 2008
Differential interactions between comorbid anxiety disorders and substance use disorder in rapid cycling bipolar I or II disorderKeming Gao, Bryan K Tolliver, David E Kemp, et al.
Journal of Affective Disorders|August 27, 2018
The safety and tolerability of aripiprazole once-monthly as maintenance treatment for bipolar I disorder: A double-blind, placebo-controlled, randomized withdrawal studyJoseph R Calabrese, Raymond Sanchez, Na Jin, et al.
The Journal of Clinical Psychiatry|November 26, 2002
Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and managementJoseph R Calabrese, John R Sullivan, Charles L Bowden, et al.
Social Psychiatry and Psychiatric Epidemiology|November 2, 2015
Latent dimensions of posttraumatic stress disorder and their relations with alcohol use disorderTracey L Biehn, Ateka A Contractor, Jon D Elhai, et al.
Psychiatry Research|June 16, 2012
The factor structure of major depression symptoms: a test of four competing models using the Patient Health Questionnaire-9Jon D Elhai, Ateka A Contractor, Marijo Tamburrino, et al.
Journal of Child and Adolescent Psychopharmacology|August 10, 2011
An open-label study of aripiprazole in children with a bipolar disorderRobert L Findling, Nora K McNamara, Eric A Youngstrom, et al.
Bipolar Disorders|March 10, 2004
Lamotrigine treatment of bipolar disorder: data from the first 500 patients in STEP-BDLauren B Marangell, James M Martinez, Terence A Ketter, et al.
Pageof 34

Showing results (221-230 of 334) with videos related to

Sort By:
Pageof 34
Medgenmed : Medscape General Medicine|April 5, 2007
Predictors of bipolar disorder risk among patients currently treated for major depressionJoseph R Calabrese, David J Muzina, David E Kemp, et al.
The Journal of Clinical Psychiatry|May 17, 2007
Double-blind, placebo-controlled trial of divalproex monotherapy in the treatment of symptomatic youth at high risk for developing bipolar disorderRobert L Findling, Thomas W Frazier, Eric A Youngstrom, et al.
The American Journal on Addictions|August 19, 2010
Independent predictors for lifetime and recent substance use disorders in patients with rapid-cycling bipolar disorder: focus on anxiety disordersKeming Gao, Philip K Chan, Marcia L Verduin, et al.
Journal of Affective Disorders|February 1, 2008
Differential interactions between comorbid anxiety disorders and substance use disorder in rapid cycling bipolar I or II disorderKeming Gao, Bryan K Tolliver, David E Kemp, et al.
Journal of Affective Disorders|August 27, 2018
The safety and tolerability of aripiprazole once-monthly as maintenance treatment for bipolar I disorder: A double-blind, placebo-controlled, randomized withdrawal studyJoseph R Calabrese, Raymond Sanchez, Na Jin, et al.
The Journal of Clinical Psychiatry|November 26, 2002
Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and managementJoseph R Calabrese, John R Sullivan, Charles L Bowden, et al.
Social Psychiatry and Psychiatric Epidemiology|November 2, 2015
Latent dimensions of posttraumatic stress disorder and their relations with alcohol use disorderTracey L Biehn, Ateka A Contractor, Jon D Elhai, et al.
Psychiatry Research|June 16, 2012
The factor structure of major depression symptoms: a test of four competing models using the Patient Health Questionnaire-9Jon D Elhai, Ateka A Contractor, Marijo Tamburrino, et al.
Journal of Child and Adolescent Psychopharmacology|August 10, 2011
An open-label study of aripiprazole in children with a bipolar disorderRobert L Findling, Nora K McNamara, Eric A Youngstrom, et al.
Bipolar Disorders|March 10, 2004
Lamotrigine treatment of bipolar disorder: data from the first 500 patients in STEP-BDLauren B Marangell, James M Martinez, Terence A Ketter, et al.
Pageof 34